Literature DB >> 376101

Erythroleukemia in a renal transplant recipient.

J A Ellerton, G A deVeber, M A Baker.   

Abstract

A 53-year-old male developed acute erythroleukemia three years after renal transplantation. He had received three years of immunosuppressive therapy with azathioprine. A preleukemia phase associated with chromosome abnormalities was recognized. Azathioprine has been associated with chromosome abnormalities. The chronic stimulation of an abnormal erythroid clone by transplantation may have hastened the development of erythroleukemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376101     DOI: 10.1002/1097-0142(197905)43:5<1924::aid-cncr2820430551>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Treatment of acute myeloid leukaemia in a renal allograft recipient: implications of cyclosporin immunosuppressive treatment.

Authors:  R J Cuthbert; N H Russell; P A Jones; A G Morgan
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

Review 2.  Hematologic abnormalities following renal transplantation.

Authors:  Mark A Marinella
Journal:  Int Urol Nephrol       Date:  2009-03-20       Impact factor: 2.266

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.